From Medscape Diabetes & Endocrinology

Coverage From The

American Diabetes Association (ADA) 79th Scientific Sessions

June 07 - 11, 2019; San Francisco, CA

June 07 - 11, 2019 San Francisco, CA

Meeting Highlights At A Glance

  • Top News From ADA 2019: Slideshow Top News From ADA 2019: Slideshow Highlights include highly anticipated cardiovascular outcomes with dulaglutide, linagliptin, dapagliflozin, and oral semaglutide, and new cardiorenal data for canagliflozin.

Conference News

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from ADA 2018

Previous Coverage